Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Okumus, E. Kiyan, A. K. Bilge, Z. Kaya, F. Comce, M. Bolayir, G. Kuran, A. Kiyan, L. Tabak, O. Arseven (Istanbul, Bolu, Turkey). Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?. Eur Respir J 2007; 30: Suppl. 51, 1804

Member's Comments

No comment yet.

Related content which might interest you: N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 509-513 Year: 2005 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007 The relationship between pro-BNP(brain natriuretic peptide), c-reactive protein(CRP) and right ventricular dysfunction in pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006 NT-proBNP reflects right ventricular structure and function in pulmonary hypertension Source: Eur Respir J 2006; 28: 1190-1194 Year: 2006 Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Biomarkers in pulmonary hypertension Source: Eur Respir J 2008; 32: 503-512 Year: 2008 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 1286-1293 Year: 2010 Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism Source: Eur Respir J 2014; 43: 1669-1677 Year: 2014 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004